Sign inJoin waitlistJoin the waitlist

Wenxin Xu

Assistant Professor of Medicine, Harvard Medical School · Mass General Brigham

Credentials: · · · ·

History

Mass General Brigham
Present
University of South Carolina-Columbia
Present

Hematology and Medical Oncology
Beth Israel Deaconess Medical Center
2017–2020
Internal Medicine
Beth Israel Deaconess Medical Center
2014–2017
Harvard Medical School
2010–2014

Research

Progressive immune dysfunction with advancing disease stage in renal cell carcinoma
Cancer Cell · 2021 · 409 citations
Checkpoint inhibitor immunotherapy in kidney cancer
Review · Nature Reviews Urology · 2020 · First of 3 authors · 221 citations
Comparison of the Superagonist Complex, ALT-803, to IL15 as Cancer Immunotherapeutics in Animal Models
Cancer Immunology Research · 2016 · 194 citations

Toni Choueiri
23 papers
David McDermott
11 papers
David Braun
10 papers
Bradley McGregor
9 papers
Chris Labaki
8 papers · 2 as a resident
Michelle Hirsch
7 papers
Rana McKay
7 papers · 4 as a resident
RS
Renee Saliby
7 papers · 3 as a resident
Sabina Signoretti
7 papers
Stephanie Berg
7 papers
Brian Rini
6 papers
DS
Deb Schrag
5 papers

Clinical trials

Pre-NEOSHIFT-RCC: Neoadjuvant HIF-Inhibitor Immunotherapy in RCC
Principal investigator · Recruiting · Phase 2
Dana-Farber Cancer Institute
2026–2029
Drug Screening Using Novel IMD in Renal Cell Carcinoma
Principal investigator · Recruiting · Phase 1
Oliver Jonas
2024–2029
Memory-like Natural Killer (NK) Cell Therapy in Patients With Renal Cell Carcinoma or Urothelial Carcinoma
Principal investigator · Active not recruiting · Early phase 1
Dana-Farber Cancer Institute
2024–2031